Paw Prosper becomes exclusive North American home for Elvation VET
Bottom line
Version 1
Paw Prosper said on September 1, 2026, that it has expanded its relationship with Elvation Medical and will now serve as the exclusive commercial home for Elvation VET Shockwave Therapy in the United States and Canada. The deal adds Elvation’s PiezoWave2T VET system, a focused piezoelectric shockwave device used in equine and small animal care, to Paw Prosper’s growing rehabilitation lineup, which already includes laser and pulsed electromagnetic field, or PEMF, offerings through brands such as Respond Animal Therapeutics. Paw Prosper has also been broadening its veterinary footprint this year through acquisitions and continuing education investments, suggesting this move is part of a larger rehabilitation and professional-services strategy. (finance.yahoo.com)
Why it matters: For veterinary professionals, the announcement points to further consolidation in the rehab and sports medicine device channel. A single distributor carrying shockwave, laser, PEMF, mobility, and education assets could make purchasing, training, and support more streamlined for practices building multimodal rehabilitation programs. At the same time, clinicians will likely keep a close eye on evidence and protocol guidance: recent reviews note that shockwave therapy is commonly used for tendon and ligament injuries, osteoarthritis, and some fracture-related applications, but the overall veterinary evidence base remains limited and uneven across indications. (pubmed.ncbi.nlm.nih.gov)
What to watch: Watch for how Paw Prosper packages training, service, and clinical education around PiezoWave2T VET, and whether the partnership expands shockwave adoption in general practice, specialty rehab, equine, and sports medicine settings. (ca.linkedin.com)
Version 2
Paw Prosper is taking a bigger role in veterinary rehabilitation distribution, announcing on September 1, 2026, that it has become the exclusive commercial partner and official home for Elvation VET Shockwave Therapy in the US and Canada. The agreement brings Elvation’s PiezoWave2T VET, a focused piezoelectric shockwave system for equine and small animal use, directly into Paw Prosper’s portfolio. (finance.yahoo.com)
The move fits a broader expansion strategy already underway at Paw Prosper. The company has been assembling a larger rehabilitation and mobility platform that includes brands tied to harnessing, wheelchairs, conditioning, laser therapy, PEMF, and professional education. Its recent acquisition of Onlinepethealth, along with an existing portfolio that includes Respond Animal Therapeutics and other rehab-adjacent brands, suggests Paw Prosper is positioning itself as a one-stop partner for practices, rehab teams, and pet parents seeking conservative care and recovery tools. (pawprosper.com)
According to the announcement, the centerpiece of the partnership is the PiezoWave2T VET, a Germany-engineered, US-assembled device that uses focused piezoelectric shockwave technology. Elvation markets the system for targeted, non-invasive treatment that supports tissue healing and pain relief, particularly in ligament and tendon cases in horses and small animals. Paw Prosper’s public materials and LinkedIn posting also frame the addition as an expansion of its modality lineup, alongside established laser and PEMF offerings. (finance.yahoo.com)
Industry reaction so far appears to be coming mainly through company channels rather than independent commentary. Paw Prosper promoted the announcement to veterinary teams on LinkedIn, emphasizing precision treatment for ligament and tendon healing. Elvation’s veterinary education ecosystem also appears active, with workshops and conference programming focused on rehabilitation indications such as distal limb tendons and joints, axial skeletal pain, myofascial conditions, postsurgical cases, and non-healing bone applications. (ca.linkedin.com)
Still, the clinical backdrop is more nuanced than the marketing language. A 2026 JAVMA review says shockwave therapy is most commonly used in veterinary medicine for tendon and ligament injuries, osteoarthritis, and nonunion fractures, and notes practical considerations including dosing, temporary analgesic effects, and the need to avoid anti-inflammatory medications or cryotherapy around treatment times. A 2022 systematic review found the evidence for clinical effects in horses and dogs remains limited overall, though some applications, including short-term pain relief, ligament conditions, and osteoarthritis, appear promising enough to justify further study. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, this is less about a single device launch than about channel strategy. Paw Prosper is building a more integrated rehab offering that could influence how clinics evaluate vendors, staff training, continuing education, and bundled modality adoption. For practices already using laser or PEMF, adding shockwave through the same commercial relationship may lower friction. For equine and sports medicine teams, the partnership could increase visibility and access to focused shockwave systems. But it also puts more weight on clinicians to separate convenience from evidence, choose indications carefully, and set realistic expectations with pet parents. (respondanimal.com)
There’s also a competitive signal here. Rehab and mobility companies have increasingly tried to pair devices with education, certification, and professional community, not just product sales. Paw Prosper’s inclusion of Canine Rehabilitation Institute and Onlinepethealth in its broader ecosystem suggests it may be able to market shockwave not only as equipment, but as part of a training-and-support pathway for veterinary teams. That could matter in a category where adoption often depends as much on confidence and workflow integration as on headline claims. (ca.linkedin.com)
What to watch: The next signals will be whether Paw Prosper launches bundled education or financing around PiezoWave2T VET, whether more independent clinicians weigh in on outcomes and case selection, and whether this partnership changes purchasing patterns in rehab, orthopedics, equine practice, and sports medicine over the next 6 to 12 months. (veterinaryshockwaveresources.com)